A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+9.58%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$441M
AUM Growth
+$441M
Cap. Flow
+$124M
Cap. Flow %
28.2%
Top 10 Hldgs %
89.53%
Holding
21
New
2
Increased
2
Reduced
1
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$106M 24%
4,168,718
EFTR
2
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$67M 15.21%
+4,822,114
New +$67M
JSPR icon
3
Jasper Therapeutics
JSPR
$45.5M
$58M 13.17%
+5,628,558
New +$58M
VERA icon
4
Vera Therapeutics
VERA
$1.38B
$51.4M 11.66%
2,960,231
PHAT icon
5
Phathom Pharmaceuticals
PHAT
$864M
$38.5M 8.74%
1,203,135
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$19M 4.32%
876,656
+5,531
+0.6% +$120K
OKUR
7
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$15.3M 3.47%
2,073,957
+111,736
+6% +$825K
SIEN
8
DELISTED
Sientra, Inc.
SIEN
$13.5M 3.06%
2,349,827
-41,016
-2% -$235K
VRNA
9
Verona Pharma
VRNA
$9.16B
$13.4M 3.04%
2,457,499
ACET icon
10
Adicet Bio
ACET
$59.9M
$12.6M 2.87%
1,615,385
SLNO icon
11
Soleno Therapeutics
SLNO
$3.6B
$9.5M 2.16%
10,302,602
NCNA
12
NuCana
NCNA
$6.09M
$8.57M 1.94%
3,333,333
XCUR icon
13
Exicure
XCUR
$35.4M
$8.23M 1.87%
6,977,000
PRTK
14
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.06M 1.15%
1,041,131
SYRE icon
15
Spyre Therapeutics
SYRE
$996M
$1.91M 0.43%
240,500
MTEM
16
DELISTED
Molecular Templates, Inc.
MTEM
$1.34M 0.3%
200,000
CBAY
17
DELISTED
Cymabay Therapeutics
CBAY
$478K 0.11%
131,036
OBSV
18
DELISTED
ObsEva SA Ordinary Shares
OBSV
$274K 0.06%
87,999
OCGN icon
19
Ocugen
OCGN
$319M
$51K 0.01%
7,111
XFOR icon
20
X4 Pharmaceuticals
XFOR
$84.2M
-229,885
Closed -$1.49M